Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer (Q39031180)

8 September 2017

title

Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer (English)

1 reference

8 September 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ilda P. Ribeiro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Carina Bernardo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paula A. Oliveira

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Rosário Pinto-Leite

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Joana Melo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Susana Isabel Ferreira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jaqueline Ferreira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Marco Filipe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Regina Arantes-Rodrigues

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Lúcio Santos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

24 January 2014

1 reference

8 September 2017

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

4599-4617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

2 June 2020

0 references

0 references

0 references

Chemotherapy in advanced bladder cancer: current status and future

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Expression Microarray Meta-Analysis Identifies Genes Associated with Ras/MAPK and Related Pathways in Progression of Muscle-Invasive Bladder Transition Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

The use of short tandem repeat profiling to characterize human bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Cell-line authentication: End the scandal of false cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

In vivo and in vitro effects of RAD001 on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Molecular genetics of human bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

What we could do now: molecular pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Cytoplasmic functions of the tumour suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Pro-tumorigenic effects of miR-31 loss in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Bladder cancer stage and outcome by array-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Urothelial tumorigenesis: a tale of divergent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

KEGG for integration and interpretation of large-scale molecular data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

canSAR: an integrated cancer public translational research and drug discovery resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

A wiki for the life sciences where authorship matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

The DNA sequence and biological annotation of human chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1604-3

Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.

21 January 2018

1 reference

12 December 2020

Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique

1 reference

12 December 2020

GeneCards Version 3: the human gene integrator

1 reference

12 December 2020

Pathobiology and chemoprevention of bladder cancer

1 reference

12 December 2020

Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma

1 reference

12 December 2020

miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer

1 reference

12 December 2020

Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes

1 reference

12 December 2020

Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750kB region at 4p16.3.

1 reference

12 December 2020

The CDKN2A (p16) gene and human cancer.

1 reference

12 December 2020

Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis

1 reference

12 December 2020

Molecular genetics of bladder cancer: targets for diagnosis and therapy.

1 reference

12 December 2020

Predicting progression of bladder urothelial carcinoma using microRNA expression

1 reference

12 December 2020

10.1007/S13277-013-1604-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24459064%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference